Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Euro Surveill ; 23(34)2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-30153883

RESUMEN

In 2015 an increased incidence of invasive meningococcal disease due to serogroup-C (MenC) occurred in Tuscany, Italy. This led the Regional Health Authority of Tuscany to implement a reactive immunisation campaign and to launch an epidemiological field investigation aiming to address targeted immunisation interventions. In 2011-14, 10 MenC cases had been reported compared with 62 cases in 2015-16. The case fatality rate was 21% (n = 13) and 51 cases (82.3%) were confirmed as C:P1.5-1,10-8:F3-6:ST-11(cc11). Overall, 17 clusters were recognised. Six discos and four gay-venues were found to have a role as transmission-hotspots, having been attended by 20 and 14 cases in the 10 days before symptoms onset. Ten and three cases occurred, respectively, among men who have sex with men (MSM) and bisexual individuals, who were involved in 11 clusters. In addition, heterosexual cases (n = 5) attending gay-venues were also found. Secondary cases were not identified. Molecular typing indicated close relationship with MenC clusters recently described among gay, bisexual and other MSM in Europe and the United States, suggesting a possible international spread of the serogroup-C-variant P1.5-1,10-8:F3-6:ST-11(cc11) in this population-group; however, epidemiological links were not identified. In December 2016, a targeted vaccination campaign involving discos and lesbian, gay, bisexual, and transgender (LGBT) associations was implemented. During 2017, 10 cases of MenC occurred, compared with 32 and 30 cases reported in 2015 and 2016 respectively, suggesting the effectiveness of the reactive and targeted immunisation programmes.


Asunto(s)
Bisexualidad , Brotes de Enfermedades , Homosexualidad Masculina , Meningitis Meningocócica/epidemiología , Meningitis Meningocócica/prevención & control , Infecciones Meningocócicas/epidemiología , Vacunas Meningococicas/administración & dosificación , Neisseria meningitidis Serogrupo C/aislamiento & purificación , Adolescente , Adulto , Anciano , Portador Sano/epidemiología , Femenino , Humanos , Programas de Inmunización , Incidencia , Italia/epidemiología , Masculino , Meningitis Meningocócica/diagnóstico , Meningitis Meningocócica/microbiología , Infecciones Meningocócicas/diagnóstico , Vacunas Meningococicas/inmunología , Neisseria meningitidis Serogrupo C/genética , Neisseria meningitidis Serogrupo C/inmunología , Serotipificación , Vacunación/estadística & datos numéricos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA